Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography.
about
Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments TrialsComparison of optical coherence tomography findings in a patient with central retinal artery occlusion in one eye and end-stage glaucoma in the fellow eye.Comparison of spectral/Fourier domain optical coherence tomography instruments for assessment of normal macular thickness.A reference standard for the measurement of macular oedema.Normative spectral domain optical coherence tomography data on macular and retinal nerve fiber layer thickness in IndiansHigh-speed, ultrahigh resolution optical coherence tomography of the retina in Hunter syndrome.Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathyOptical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edemaAssessment of artifacts and reproducibility across spectral- and time-domain optical coherence tomography devices.Macular thickness measurements in healthy Norwegian volunteers: an optical coherence tomography study.OCT reveals regional differences in macular thickness with ageNormative database for separate inner retinal layers thickness using spectral domain optical coherence tomography in Caucasian population.Capillary pressure may predict preclinical changes in the eyeIn diabetic eyes, multifocal ERG reflects differences in function between the nasal part and the temporal part of the macula.VEGFA and VEGFR2 gene polymorphisms and response to anti-vascular endothelial growth factor therapy: comparison of age-related macular degeneration treatments trials (CATT).A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis.Macular thickness by age and gender in healthy eyes using spectral domain optical coherence tomography.Thickness mapping of retinal layers by spectral-domain optical coherence tomography.Cone structure in patients with usher syndrome type III and mutations in the Clarin 1 gene.Familial asymptomatic macular telangiectasia type 2.Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT)Comparison of natural course, intravitreal triamcinolone and macular laser photocoagulation for treatment of mild diabetic macular edema.Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusionSuccess with single-agent immunosuppression for multifocal choroidopathies.Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials.Topical mecamylamine for diabetic macular edemaPostoperative metamorphopsia in macula-off rhegmatogenous retinal detachment: associations with visual function, vision related quality of life, and optical coherence tomography findings.The use of optical coherence tomography to determine the effect of thiazolidinediones on retinal thickness in patients with type 2 diabetes.Retinal thickness measurement obtained with spectral domain optical coherence tomography assisted optical biopsy accurately correlates with ex vivo histology.Thickness mapping of eleven retinal layers segmented using the diffusion maps method in normal eyesIdentifying a clinically meaningful threshold for change in uveitic macular edema evaluated by optical coherence tomographyMacular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments TrialsIdiopathic juxtafoveal retinal telangiectasis: new findings by ultrahigh-resolution optical coherence tomography.A cross-sectional study of submacular thickening in intermediate uveitis and determination of treatment threshold.On the relationship between visual acuity and central retinal (macular) thickness after interventions for macular oedema in diabetics: a review.Comparison of central macular thickness between two spectral-domain optical coherence tomography in elderly non-mydriatic eyes.Optical Coherence Tomography in the UK Biobank Study - Rapid Automated Analysis of Retinal Thickness for Large Population-Based StudiesMacular thickness and macular volume measurements using spectral domain optical coherence tomography in normal Nepalese eyes.Macular thickness changes evaluated with spectral domain optical coherence tomography after uncomplicated phacoemulsification.Intravenous bevacizumab causes regression of choroidal neovascularization secondary to diseases other than age-related macular degeneration.
P2860
Q28049700-99AA8E89-C522-4EB0-A972-667000257DB2Q30426828-54AADB39-C4F0-4FA1-B282-9C15BDD50574Q30477394-6CC80AB1-5B3B-430F-8A03-A05456A40013Q30487091-509925CF-7988-4DD3-B6A0-EB68EF24F203Q30665242-FA23E694-D7B2-4304-901F-E41E1BA2CF1CQ33303572-C2DAF863-0EE9-4691-B507-1BBD48C2DC99Q33320901-5EBF8F48-3D29-4124-9058-B0A913C5C817Q33357187-FF685144-AC73-49F5-814A-3E4A327B31B3Q33480756-8355B06D-F96E-410C-A2AF-94F67A18F125Q33577384-E2652C3F-202E-45D1-A50E-18EFC3007840Q33737573-85DAAEE9-A003-418E-B449-AC3ADAE0CFD7Q33874143-3A0CF90E-5EEC-4CD8-94D9-49005BBBB6FBQ34023566-5DB9780E-073C-4541-AFB3-BD6D8EF702D2Q34158054-54D0004E-FDC8-4AF6-B5DC-D26E0B5B3CF2Q34170457-64AA23D2-70DD-4E97-B384-0E0A90C2F8EEQ34257553-5E28BA83-A4BF-4552-B507-1C416857B3FDQ34282096-85434F0D-22AC-4609-95DA-F724FADD2F32Q34348413-57F32932-36DD-44A7-B750-8BAC5E407F7BQ34410659-611AE433-124A-4B3F-B376-484DCDB3C503Q34443065-E46C489F-C98D-436A-A93B-C8721CDEDD81Q34556444-011B9E01-3E90-4C90-BD3C-9CC92800971BQ34570768-325C3BBE-B335-428A-A3D5-71EEF4ADD5A1Q34588134-CF5FF2CD-25B6-4370-A7D4-F10C3247D85DQ34623981-CCC524C7-CFDB-475A-8732-66686D53869AQ34705570-0ACF27D5-EB4B-4CB9-B166-83E62B48FFCBQ35126358-43471497-904A-40A2-ABF5-EBC2655D7F28Q35326429-F30CF68E-F3C0-4CDF-A1B8-8130CAEB5CD5Q35337098-458A41E2-5EFD-4229-A81A-51E229F18396Q35381449-9A93CC29-3DF0-487F-9558-06F454DF6E0AQ35563462-03E6322C-B0EB-49AC-B533-DE5A3FDD2F64Q35570770-3B8FA531-2190-496D-9E3D-2B100DB20C42Q35897354-A4CCB868-446F-45BC-B519-D07B7D648680Q35928369-4E91586E-0FA0-4721-B1B9-614ACC1B1B9FQ36020190-F0C1DC7A-AF11-47BD-ADF0-5DEB54263291Q36056409-A25C3006-4FAB-49A7-816E-D355B6EA414FQ36072389-5789B6FF-6B1D-4B42-A8D5-0C5679D21284Q36157730-7036684A-C13C-4451-BDD0-A01281FAF870Q36738103-232B3701-461A-4939-9CD8-43C6AED9B2ECQ36832291-527BEF33-62CF-4D09-9DDD-222B787D1CCBQ36904061-A2B5D757-F20A-469E-9C31-E8F7B5C35008
P2860
Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Normal macular thickness measu ...... optical coherence tomography.
@ast
Normal macular thickness measu ...... optical coherence tomography.
@en
type
label
Normal macular thickness measu ...... optical coherence tomography.
@ast
Normal macular thickness measu ...... optical coherence tomography.
@en
prefLabel
Normal macular thickness measu ...... optical coherence tomography.
@ast
Normal macular thickness measu ...... optical coherence tomography.
@en
P2093
P2860
P1433
P1476
Normal macular thickness measu ...... s optical coherence tomography
@en
P2093
Annie Chan
James G Fujimoto
Jay S Duker
P2860
P304
P356
10.1001/ARCHOPHT.124.2.193
P407
P577
2006-02-01T00:00:00Z